Diagnostic and prognostic value of antioxidant enzyme assay in erythrocytes of patients with end stage renal disease treated with hemodialysis

   
Vavilova T.P.1 , Geva O.N.1, Pushkina A.V.2 ">, Tkachev G.A.1, Koretskaya N.A.1

1. Moscow State Medical Stomatological University
2. OOO "Fespharm"
Section: Short Communication
UDK: 577.27:591.81      PubMed Id: 16805395
Year: 2006  Volume: 52  Issue: 2  Pages: 219-222
Anemia is one of the main complications seen in patients with end stage renal disease (ESRD) treated with hemodialysis. We hypothesized that oxidative stress and decrease of antioxidant defense enzyme activity may be major causes underlying functional insufficiency of erythrocytes. Blood samples of 16 patients with ESRD undergoing hemodialysis were investigated. All patients received Recormon for treatment of anemia. In spite of effective hemodialysis procedures cleared patient blood the erythrocyte activities of superoxide dismutase (SOD), glutathione peroxidase (GP) were lower than in healthy controls and hemodialysis procedure insignificantly influenced enzyme activities. After 6 months repeated study of the erythrocyte enzymes revealed further decrease of SOD and GP activities.
Download PDF:
Reference:

Vavilova T.P., Geva O.N., Pushkina A.V., Tkachev G.A., Koretskaya N.A. (2006) Biomeditsinskaya khimiya, 52(2), 219-222.
References  
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)
        

© Institute of Biomedical Chemistry, Moscow, Russia